ATC
Adirondack Trust Company Portfolio holdings
AUM
$275M
This Quarter Return
+8.19%
1 Year Return
+15.53%
3 Year Return
+72.21%
5 Year Return
+122.25%
10 Year Return
+250.85%
AUM
$123M
AUM Growth
+$123M
(+8.6%)
Cap. Flow
+$1.2M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
41.41%
Holding
314
New
11
Increased
59
Reduced
35
Closed
13
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$458K |
| 2 |
iShares MSCI EAFE ETF
EFA
|
$355K |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$212K |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
$185K |
| 5 |
Caterpillar
CAT
|
$178K |
Top Sells
| 1 |
iShares TIPS Bond ETF
TIP
|
$1.05M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$424K |
| 3 |
SPDR Gold Trust
GLD
|
$101K |
| 4 |
NSM
Nationstar Mortgage Holdings
NSM
|
$84K |
| 5 |
Southern Copper
SCCO
|
$58K |
Sector Composition
| 1 | Industrials | 10.35% |
| 2 | Healthcare | 10.3% |
| 3 | Technology | 9.66% |
| 4 | Consumer Staples | 9.11% |
| 5 | Energy | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cassava Sciences
SAVA
$110M
| – | – |
-200
| Closed | -$1K |
|
|
302
Southern Copper
SCCO
$78B
| – | – |
-2,122
| Closed | -$58K |
|
|
TMQ
303
Trilogy Metals
TMQ
$278M
| $0 | ﹤0.01% |
125
| – | – |
|
|
304
Vanguard S&P 500 ETF
VOO
$726B
| – | – |
-5,507
| Closed | -$424K |
|
|
VIRX
305
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-1,000
| Closed | -$5K |
|
|
CHK
306
DELISTED
Chesapeake Energy Corporation
CHK
| – | – |
-200
| Closed | -$5K |
|
|
NSM
307
DELISTED
Nationstar Mortgage Holdings
NSM
| – | – |
-1,500
| Closed | -$84K |
|
|
WAC
308
DELISTED
Walter Investment Mgt Corp
WAC
| – | – |
-665
| Closed | -$26K |
|
|
BRCM
309
DELISTED
BROADCOM CORP CL-A
BRCM
| – | – |
-240
| Closed | -$6K |
|
|
ELN
310
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
| – | – |
-540
| Closed | -$8K |
|
|
JSDA
311
DELISTED
JONES SODA CO
JSDA
| $0 | ﹤0.01% |
250
| – | – |
|
|
YELL
312
DELISTED
Yellow Corporation Common Stock
YELL
| $0 | ﹤0.01% |
2
| – | – |
|
|
GCVRZ
313
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $0 | ﹤0.01% |
35
| – | – |
|